|
Intermediates
1.
1-Boc-4-piperidinemethanol: 99%
2.
Iodobenzene diacetate:98%
3.
Piperidine-4-Carboxamide:98%
4.
4-Androstene-3,17-Dione
5.
Androsta-1,4 Diene-3,17-Dione
6.
Beta-lonone
APIS
1. Ligustrazine
HCl:
in-House
2.
monobenzone:98.5%
3.
Deoxifluridine 98.5%
4. Docetaxel
98.5%
5.
Angoroside C:99%
6. (+)-Bicuculline
:99%
7.
Celastrol:99%
8. Sorafenib
Tosylate:99%
9. Imatinib
mesylate:99%
10. Lenalidomide:98%
11. Lapatinib Ditosylate:99%
12. Erlotinib HCL :99%
13. Gefitinib :98%
14. Dasatinib monohydrate :99%
15. Sunitinib malate:99%
16. Entecavir Monohydrate:99%
17. Decitabine:98.5%
18. Deferasirox:98.5%
19. D-tetrahydropalmatine:98%
20. Gemcitabine HCL: USP29
21. Idarubicin HCL:98%
22. Mitomycin C :USP
23. Tacrolimus:99%
24. Bosentan:99%
25.
Melphalan:USP28
26.
Tacrolimus:99%
27.
Vancomyycin HCL USP/EP/JP
28. Teicoplanin JP
29. Kitasamycin JP/CP
30. Levofloxacin In-house
31. Rifampicin O in-House
32. Rifampicin s in-House
33. pristinamycin in-House
34. Miglitol in-House
25. Voglibose and intermediates in-House
26. Sirolimus in-House
27. Everolimus in-House
28. ABT-578 in-House
29. Tacrolimus in-House
30. Exemestane in-House
|